STONKWHISPER
← Back to Intel
Insider ActivityMLYS

Rodman David Malcom, Chief Medical Officer at Mineralys Therapeutics, Inc., sold $373K of MLYS

Updated Jun 15, 2026
Rodman David Malcom Chief Medical Officer
Mineralys Therapeutics, Inc. · $MLYS
$373K Total Value
14,058 Shares Traded
$26.5391 Price / Share
76,140 Shares Owned After
2026-04-15 Filing Date

Transaction Details

InsiderRodman David Malcom
TitleChief Medical Officer
CompanyMineralys Therapeutics, Inc.
TickerMLYS
Transaction TypeSale
Transaction Date2026-04-13
Shares Traded14,058
Price Per Share$26.5391
Total Value$373K
Filed Date2026-04-15
Accession Number0001933414-26-000076

Ownership Context

Shares Owned After Transaction76,140
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001933414-26-000076

Other Insider Trades — MLYS

Other Trades by Rodman David Malcom

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MLYS — Mineralys Therapeutics, Inc. →

Track MLYS insider activity in real time on The Wire →

Get alerts when Rodman David Malcom files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 15, 2026 at 07:18 UTC

Want real-time data? Access The Wire for live sentiment tracking.